109 Tumor-related Epilepsy

Monday, April 30
7:00 am - 9:00 am
Location: 292; Ernest N. Morial

Fee: $100
Advanced Practice Provider Fee: $100
Candidate and Medical Student Fee: $65

Moderator(s): Mitchel S. Berger, MD, FAANS

Panelist(s): Richard W. Byrne, MD, FAANS; Edward F. Chang, MD, FAANS; Jeffrey M Politsky, MD, FRCP(C)

This seminar will provide an overview of the management of tumor-related seizures and refractory epilepsy. We will discuss how to optimize seizure control during surgical resections, including the use of pre- and intraoperative electrophysiological approaches, as well as decision making resection strategies such as when to perform an amygdalohippocampectomy. The use and efficacy of pre-operative and post-operative anti-epileptic medications also will be discussed.

Learning Objectives: After completing this educational activity, participants should be able to:

  • Review the surgical outcomes for seizure control for patients with tumor-related epilepsy.
  • Describe important technical consideration in surgical resection to optimize both tumor and seizure control including the use of awake mapping, electrocorticography and hippocampectomy.
  • Recognize the utility of preoperative and post-operative anti-epileptic medication in controlling seizures.